- Home
- OM vs TRDA Comparison
OM vs TRDA Comparison
Compare OM & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OM
- TRDA
- Stock Information
- Founded
- OM 2003
- TRDA 2016
- Country
- OM United States
- TRDA United States
- Employees
- OM N/A
- TRDA N/A
- Industry
- OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
- TRDA Biotechnology: Pharmaceutical Preparations
- Sector
- OM Health Care
- TRDA Health Care
- Exchange
- OM Nasdaq
- TRDA Nasdaq
- Market Cap
- OM 247.1M
- TRDA 233.5M
- IPO Year
- OM 2020
- TRDA 2021
- Fundamental
- Price
- OM $13.69
- TRDA $5.28
- Analyst Decision
- OM Hold
- TRDA Strong Buy
- Analyst Count
- OM 1
- TRDA 3
- Target Price
- OM $22.00
- TRDA $25.67
- AVG Volume (30 Days)
- OM 156.6K
- TRDA 231.6K
- Earning Date
- OM 11-05-2025
- TRDA 11-04-2025
- Dividend Yield
- OM N/A
- TRDA N/A
- EPS Growth
- OM N/A
- TRDA N/A
- EPS
- OM N/A
- TRDA N/A
- Revenue
- OM $119,304,000.00
- TRDA $79,476,000.00
- Revenue This Year
- OM $12.37
- TRDA N/A
- Revenue Next Year
- OM $10.52
- TRDA N/A
- P/E Ratio
- OM N/A
- TRDA N/A
- Revenue Growth
- OM 2.47
- TRDA N/A
- 52 Week Low
- OM $5.85
- TRDA $4.93
- 52 Week High
- OM $25.35
- TRDA $21.79
- Technical
- Relative Strength Index (RSI)
- OM 45.01
- TRDA 42.86
- Support Level
- OM $13.30
- TRDA $5.08
- Resistance Level
- OM $14.43
- TRDA $5.53
- Average True Range (ATR)
- OM 0.63
- TRDA 0.26
- MACD
- OM 0.16
- TRDA 0.02
- Stochastic Oscillator
- OM 47.89
- TRDA 18.87
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.